Read the pitch deck these Stanford grads used to raise $11.6 million for a wearable device to track women's hormones

In a bold move to address a significant gap in the $100 billion wearable technology market, two graduates from Stanford University have launched a startup focused on women's health. Clair Health, co-founded by 22-year-old CEO Jenny Duan and 24-year-old CTO Abhinav Agarwal, has successfully raised $11.6 million in seed funding to create an innovative bracelet designed to monitor women's hormonal levels. While established brands like Oura, Whoop, and Fitbit have begun to incorporate features for women's health, such as menstrual cycle tracking, Clair Health emphasizes that its product is specifically engineered for comprehensive hormone monitoring. "This area has often been overlooked and considered niche," Duan stated. "It’s time for a company to prioritize women's health in its mission." Agarwal echoed her sentiments, questioning the current methods of hormone tracking. "If hormones are fundamental to women's health, then why isn’t there a more effective way to monitor them?" he asked. The funding round was spearheaded by Khosla Ventures, with additional contributions from a16z Speedrun, Brydge Club, Treehub, Cartan Capital, AGI House, Insiders VC, and Anne Wojcicki. The bracelet utilizes a proprietary mathematical model that simulates the interaction between the brain and ovaries in regulating hormones. The capital raised will facilitate further research and expedite the launch of both the device and its accompanying app, slated for release in November. Currently, Clair Health employs seven full-time staff members alongside approximately 14 contractors and part-time workers. Duan and Agarwal's partnership blossomed during a Stanford-organized spring break trip, where they discovered mutual interests. Duan’s experience in women's health advocacy combined with Agarwal’s background in glucose monitoring led to the creation of Clair Health. The initial production run of 5,000 devices has already sold out, with over 25,000 individuals on a waiting list. Early purchasers secured the device for $295, which included a complimentary app subscription. Eventually, the retail price is expected to reach $369, along with a paid subscription option. Clair Health's pitch deck, which played a crucial role in their funding success, has been made available, albeit with some slides redacted for public sharing.